Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Subcutaneous ketamine bolus during painful wound care in palliative care
2015-000202-20Phase 2Active
- Sponsor
- Groupement des Hôpitaux de l'Institut Catholique de Lille
- Start
- Jun 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of ketamine in pain, vascular ulcer, Peptic ulcer disease (PUD) and 1 more, sponsored by Groupement des Hôpitaux de l'Institut Catholique de Lille. Primary endpoint: Pain evaluation during care. Started Jun 2015; status: active.
02
Drugs
ketamine
03
Conditions
painvascular ulcerPeptic ulcer disease (PUD)decubitus ulcer
Beyond the preview
Go deeper on 2015-000202-20.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-000202-20.